These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.
Novo Nordisk’s Ozempic, Wegovy, and Rybelsus are all part of the same category of drugs called semaglutides, which originally were developed to treat type 2 diabetes—in part by helping people shed pounds better than any previous medication and therefore control their blood sugar. But it wasn’t until recently that their weight-loss feature propelled them to be among the most in-demand prescription medications. Still, the drugs aren’t without controversy over inappropriate use and side effects, including stomach and intestinal issues, that have prompted a warning from the FDA.
More Must-Reads From TIME
- The 100 Most Influential People of 2024
- How Far Trump Would Go
- Why Maternity Care Is Underpaid
- Scenes From Pro-Palestinian Encampments Across U.S. Universities
- Saving Seconds Is Better Than Hours
- Why Your Breakfast Should Start with a Vegetable
- Welcome to the Golden Age of Ryan Gosling
- Want Weekly Recs on What to Watch, Read, and More? Sign Up for Worth Your Time
